Transcriptomic profiling and risk assessment in bladder cancer: Insights from copper death-related genes
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Copper death-related genes (CRGs) impact bladder cancer (BC) progression. Identifying key genes like LIPT1 and molecular subtypes can improve BC risk assessment and treatment strategies.
Area Of Science
- Genomics
- Oncology
- Molecular Biology
Background
- Investigating the role of copper death-related genes (CRGs) in bladder cancer (BC).
- Aiming to improve prognosis assessment for BC patients.
Purpose Of The Study
- To elucidate the role of CRGs in BC progression.
- To develop improved risk assessment models for BC.
- To identify key genes and molecular subtypes influencing BC prognosis.
Main Methods
- Utilized multi-omics techniques to analyze CRG expression in BC tissues.
- Analyzed data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.
- Employed consensus clustering to categorize BC patients into molecular subtypes based on clinical characteristics and immune cell infiltration.
Main Results
- Developed an innovative risk assessment model identifying eight critical genes associated with BC risk.
- Validated the significant impact of LIPT1 on copper-induced cell death, proliferation, migration, and invasion in BC through in vitro and in vivo experiments.
Conclusions
- Multi-omics analysis highlights the pivotal role of CRGs in BC progression.
- Molecular subtype categorization and identification of key genes like LIPT1 offer enhanced BC risk assessment.
- Findings provide insights for improved diagnosis and treatment strategies for BC patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.